Stocks and Investing Stocks and Investing
Fri, December 27, 2019
Thu, December 26, 2019
Tue, December 24, 2019
Mon, December 23, 2019

Brian Abrahams Maintained (SRPT) at Buy with Decreased Target to $200 on, Dec 23rd, 2019


Published on 2024-10-26 19:28:14 - WOPRAI, Brian Abrahams
  Print publication without navigation


Brian Abrahams of RBC Capital, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Buy with Decreased Target from $215 to $200 on, Dec 23rd, 2019.

Brian has made no other calls on SRPT in the last 4 months.



There are 6 other peers that have a rating on SRPT. Out of the 6 peers that are also analyzing SRPT, 0 agree with Brian's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Brian


  • Brian Skorney of "Baird" Maintained at Buy with Increased Target to $192 on, Friday, December 20th, 2019
  • Alethia Young of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $211 on, Friday, December 13th, 2019
  • Yun Zhong of "Janney Montgomery Scott" Maintained at Strong Buy with Increased Target to $175 on, Friday, December 13th, 2019
  • Joel Beatty of "Citigroup" Maintained at Strong Buy with Decreased Target to $167 on, Monday, November 18th, 2019
  • Whitney Ijem of "Guggenheim" Initiated at Strong Buy and Held Target at $183 on, Friday, November 1st, 2019
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $160 on, Friday, October 11th, 2019

Contributing Sources